These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 23837925)
1. Assessment of the effect of efflux pump inhibitors on in vitro antimicrobial susceptibility of multidrug-resistant Acinetobacter baumannii. Yang Y; Chua KL Int J Antimicrob Agents; 2013 Sep; 42(3):283-4. PubMed ID: 23837925 [No Abstract] [Full Text] [Related]
2. The effect of the efflux pump inhibitor Carbonyl Cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii. Sanchez-Carbonel A; Mondragón B; López-Chegne N; Peña-Tuesta I; Huayan-Dávila G; Blitchtein D; Carrillo-Ng H; Silva-Caso W; Aguilar-Luis MA; Del Valle-Mendoza J PLoS One; 2021; 16(12):e0259915. PubMed ID: 34919563 [TBL] [Abstract][Full Text] [Related]
3. Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital. Huang L; Sun L; Xu G; Xia T Diagn Microbiol Infect Dis; 2008 Nov; 62(3):326-32. PubMed ID: 18687557 [TBL] [Abstract][Full Text] [Related]
4. Effect of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on killing Acinetobacter baumannii by colistin. Park YK; Ko KS J Microbiol; 2015 Jan; 53(1):53-9. PubMed ID: 25557480 [TBL] [Abstract][Full Text] [Related]
5. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics. Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528 [TBL] [Abstract][Full Text] [Related]
6. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex. Lin L; Ling BD; Li XZ Int J Antimicrob Agents; 2009 Jan; 33(1):27-32. PubMed ID: 18790612 [TBL] [Abstract][Full Text] [Related]
7. Functional Characterization of AbaQ, a Novel Efflux Pump Mediating Quinolone Resistance in Acinetobacter baumannii. Pérez-Varela M; Corral J; Aranda J; Barbé J Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941648 [No Abstract] [Full Text] [Related]
8. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex. Ruzin A; Keeney D; Bradford PA J Antimicrob Chemother; 2007 May; 59(5):1001-4. PubMed ID: 17363424 [TBL] [Abstract][Full Text] [Related]
9. Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide. Pannek S; Higgins PG; Steinke P; Jonas D; Akova M; Bohnert JA; Seifert H; Kern WV J Antimicrob Chemother; 2006 May; 57(5):970-4. PubMed ID: 16531429 [TBL] [Abstract][Full Text] [Related]
10. Distribution of AdeABC efflux system genes in genotypically diverse strains of clinical Acinetobacter baumannii. Wieczorek P; Sacha P; Czaban S; Hauschild T; Ojdana D; Kowalczuk O; Milewski R; Poniatowski B; Nikliński J; Tryniszewska E Diagn Microbiol Infect Dis; 2013 Oct; 77(2):106-9. PubMed ID: 23886790 [TBL] [Abstract][Full Text] [Related]
11. Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii. Kuo HY; Chang KC; Kuo JW; Yueh HW; Liou ML Int J Antimicrob Agents; 2012 Jan; 39(1):33-8. PubMed ID: 21996406 [TBL] [Abstract][Full Text] [Related]
12. Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii. Peleg AY; Adams J; Paterson DL Antimicrob Agents Chemother; 2007 Jun; 51(6):2065-9. PubMed ID: 17420217 [TBL] [Abstract][Full Text] [Related]
14. In vitro synergistic effect of amlodipine and imipenem on the expression of the AdeABC efflux pump in multidrug-resistant Acinetobacter baumannii. Hu C; Li Y; Zhao Z; Wei S; Zhao Z; Chen H; Wu P PLoS One; 2018; 13(6):e0198061. PubMed ID: 29856791 [TBL] [Abstract][Full Text] [Related]
15. [Multi-drug efflux pumps and antibiotic resistance in Acinetobacter baumannii]. Opazo AC; Mella SM; Domínguez MY; Bello HT; González GR Rev Chilena Infectol; 2009 Dec; 26(6):499-503. PubMed ID: 20098782 [TBL] [Abstract][Full Text] [Related]
17. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009. Morfin-Otero R; Dowzicky MJ Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546 [TBL] [Abstract][Full Text] [Related]
18. False susceptibility to amikacin by VITEK 2 in Acinetobacter baumannii harboring armA. Jung S; Yu JK; Shin SH; Park KG; Jekarl DW; Han K; Park YJ Ann Clin Lab Sci; 2010; 40(2):167-71. PubMed ID: 20421629 [TBL] [Abstract][Full Text] [Related]
19. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii. Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963 [TBL] [Abstract][Full Text] [Related]
20. Successful treatment of multidrug resistant Acinetobacter baumannii meningitis. Saçar S; Turgut H; Cenger DH; Coşkun E; Asan A; Kaleli I J Infect Dev Ctries; 2007 Dec; 1(3):342-4. PubMed ID: 19734617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]